Polycation-siRNA nanoparticles can disassemble at the kidney glomerular basement membrane

Proceedings of the National Academy of Sciences of the United States of America

Volumn 109, Issue 8, 2012, Pages 3137-3142

  Zuckerman, Jonathan E ^a   Choi, Chung Hang J ^a   Han, Han ^a   Davis, Mark E ^a  

^a California Institute of Technology   (United States)

Author keywords

Glomerulus; Pharmacokinetics

Indexed keywords

CYCLODEXTRIN; NANOPARTICLE; POLYCATION; SMALL INTERFERING RNA;

ANIMAL TISSUE; ARTICLE; COMPARTMENT MODEL; CONFOCAL MICROSCOPY; CONTROLLED STUDY; ELECTRON MICROSCOPY; GLOMERULAR FILTRATION BARRIER; GLOMERULUS BASEMENT MEMBRANE; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; PLASMA; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; STATIC ELECTRICITY;

ANIMALS; GLOMERULAR BASEMENT MEMBRANE; HEPARITIN SULFATE; INJECTIONS, INTRAVENOUS; KINETICS; MICE; MODELS, BIOLOGICAL; NANOPARTICLES; POLYAMINES; POSITRON-EMISSION TOMOGRAPHY; RNA, SMALL INTERFERING;

EID: 84857438167     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1200718109     Document Type: Article

References (30)

1. Castanotto D, Rossi JJ (2009) The promises and pitfalls of RNA-interference-based therapeutics. Nature 457:426-433.
2. de Fougerolles A, Vornlocher HP, Maraganore J, Lieberman J (2007) Interfering with disease: A progress report on siRNA-based therapeutics. Nat Rev Drug Discov 6: 443-453. (Pubitemid 47064567)
3. Davis ME, Chen ZG, Shin DM (2008) Nanoparticle therapeutics: An emerging treatment modality for cancer. Nat Rev Drug Discov 7:771-782.
4. Davis ME, et al. (2010) Evidence of RNAi in humans from systemically administered siRNA via targeted nanoparticles. Nature 464:1067-1070.
5. de Wolf HK, et al. (2007) Effect of cationic carriers on the pharmacokinetics and tumor localization of nucleic acids after intravenous administration. Int J Pharm 331: 167-175. (Pubitemid 46216670)
6. Malek A, et al. (2009) In vivo pharmacokinetics, tissue distribution and underlying mechanisms of various PEI(-PEG)/siRNA complexes. Toxicol Appl Pharmacol 236: 97-108.
7. Merkel OM, et al. (2009) Stability of siRNA polyplexes from poly(ethylenimine) and poly(ethylenimine)-g-poly(ethylene glycol) under in vivo conditions: Effects on pharmacokinetics and biodistribution measured by Fluorescence Fluctuation Spectroscopy and Single Photon Emission Computed Tomography (SPECT) imaging. J Control Release 138:148-159.
8. Merkel OM, et al. (2010) Triazine dendrimers as nonviral vectors for in vitro and in vivo RNAi: The effects of peripheral groups and core structure on biological activity. Mol Pharm 7:969-983.
9. Gao S, et al. (2009) The effect of chemical modification and nanoparticle formulation on stability and biodistribution of siRNA in mice. Mol Ther 17:1225-1233.
10. Bartlett DW, Su H, Hildebrandt IJ, Weber WA, Davis ME (2007) Impact of tumor-specific targeting on the biodistribution and efficacy of siRNA nanoparticles measured by multimodality in vivo imaging. Proc Natl Acad Sci USA 104:15549-15554. (Pubitemid 47502954)
11. Heidel JD, et al. (2007) Administration in non-human primates of escalating intravenous doses of targeted nanoparticles containing ribonucleotide reductase subunit M2 siRNA. Proc Natl Acad Sci USA 104:5715-5721. (Pubitemid 47175600)
12. Ribas A, et al. (2010) Systemic delivery of siRNA via targeted nanoparticles in patients with cancer: Results from a first-in-class phase I clinical trial. J Clin Oncol 28:3022.
13. Choi HS, et al. (2007) Renal clearance of quantum dots. Nat Biotechnol 25:1165-1170.
14. Choi CH, Zuckerman JE, Webster P, Davis ME (2011) Targeting kidney mesangium by nanoparticles of defined size. Proc Natl Acad Sci USA 108:6656-6661.
15. Kanwar YS, Farquhar MG (1979) Presence of heparan sulfate in the glomerular basement membrane. Proc Natl Acad Sci USA 76:1303-1307. (Pubitemid 9143728)
16. Ogawa S, et al. (1999) High-resolution ultrastructural comparison of renal glomerular and tubular basement membranes. Am J Nephrol 19:686-693.
17. Lahdenkari A-T, et al. (2004) Podocytes are firmly attached to glomerular basement membrane in kidneys with heavy proteinuria. J Am Soc Nephrol 15:2611-2618. (Pubitemid 41103367)
18. Bartlett DW, Davis ME (2007) Effect of siRNA nuclease stability on the in vitro and in vivo kinetics of siRNA-mediated gene silencing. Biotechnol Bioeng 97:909-921. (Pubitemid 47051060)
19. Oney S, et al. (2009) Development of universal antidotes to control aptamer activity. Nat Med 15:1224-1228.
20. Mishra S, Heidel JD, Webster P, Davis ME (2006) Imidazole groups on a linear, cyclodextrin- containing polycation produce enhanced gene delivery via multiple processes. J Control Release 116:179-191. (Pubitemid 44854276)
21. Comper WD, Lee AS, Tay M, Adal Y (1993) Anionic charge concentration of rat kidney glomeruli and glomerular basement membrane. Biochem J 289:647-652. (Pubitemid 23074944)
22. Westberg NG, Michael AF (1970) Human glomerular basement membrane. Preparation and composition. Biochemistry 9:3837-3846.
23. Takemoto M, et al. (2002) A new method for large scale isolation of kidney glomeruli from mice. Am J Pathol 161:799-805. (Pubitemid 34988366)
24. Molitoris BA, et al. (2009) siRNA targeted to p53 attenuates ischemic and cisplatin-induced acute kidney injury. J Am Soc Nephrol 20:1754-1764.
25. Kanwar YS, Farquhar MG (1979) Anionic sites in the glomerular basement membrane. In vivo and in vitro localization to the laminae rarae by cationic probes. J Cell Biol 81: 137-153. (Pubitemid 9148443)
26. Burke RS, Pun SH (2008) Extracellular barriers to in Vivo PEI and PEGylated PEI polyplex- mediated gene delivery to the liver. Bioconjug Chem 19:693-704. (Pubitemid 351431402)
27. Foglieni C, et al. (2000) Glomerular filtration is required for transfection of proximal tubular cells in the rat kidney following injection of DNA complexes into the renal artery. Gene Ther 7:279-285. (Pubitemid 30119730)
28. Andrews PM, Bates SB (1985) Dose-dependent movement of cationic molecules across the glomerular wall. Anat Rec 212:223-231. (Pubitemid 15247826)
29. Bennett KM, et al. (2008)) MRI of the basement membrane using charged nanoparticles as contrast agents. Magn Reson Med 60:564-574.
30. Bartlett DW, Davis ME (2007) Physicochemical and biological characterization of targeted, nucleic acid-containing nanoparticles. Bioconjug Chem 18:456-468. (Pubitemid 46493517)